Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
ACS Medicinal Chemistry Letters|October 18, 2019
Peptide-Cleavable Self-immolative Maytansinoid Antibody-Drug Conjugates Designed To Provide Improved Bystander KillingJuliet A Costoplus, Karen H Veale, Qifeng Qiu, et al.
Morphologie : Bulletin De L'Association Des Anatomistes|March 21, 2021
The accessory heads of the muscles flexor pollicis longus and flexor digitorum profundus (Gantzer muscle) - An anatomical study in Brazilian cadaversK M Oliveira, C B Breder, E F Ponte, et al.
Bioconjugate Chemistry|April 9, 2017
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid ConjugatesXiuxia Sun, Jose F Ponte, Nicholas C Yoder, et al.
Bioconjugate Chemistry|September 11, 2015
Development of Anilino-Maytansinoid ADCs that Efficiently Release Cytotoxic Metabolites in Cancer Cells and Induce High Levels of Bystander KillingWayne C Widdison, Jose F Ponte, Jennifer A Coccia, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 30, 2013
Treatment planning systems dosimetry auditing project in PortugalM C Lopes, A Cavaco, K Jacob, et al.
Molecular Cancer Therapeutics|February 15, 2018
A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs)Michael L Miller, Manami Shizuka, Alan Wilhelm, et al.
Molecular Cancer Therapeutics|February 15, 2018
<i>In Vitro</i> and <i>In Vivo</i> Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial CancersGary Altwerger, Elena Bonazzoli, Stefania Bellone, et al.
Pageof 7